
On Monday, July 19, the European Commission approved Spain’s proposal to set up a €1 billion (US$1.17 billion) recapitalization fund to help the recovery of Spanish companies affected by the coronavirus pandemic.
“This €1 billion recapitalization scheme will enable Spain to support companies affected by the coronavirus outbreak by facilitating their access to finance in these difficult times,” Executive Vice-President Margrethe Vestager said in a statement.
The Recapitalization Fund for companies affected by COVID-19 outbreak will invest through debt and equity instruments to provide capital support to the most affected companies.
Companies in all sectors, except those in the financial sector, are eligible for the scheme, unless they have already received aid under another recovery fund.
Only companies that were not considered in financial difficulty before December 19, 2019, are eligible for the aid.
“The Commission concluded that the measure is necessary, appropriate and proportionate to remedy a serious disturbance in the economy of Spain,” the EC stated.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas